A Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2023
This article has no abstract
Epistemonikos ID: d96576af65b546bbb5bef1559d0db0a3b1ab2d30
First added on: Oct 03, 2023